HMC
Honda Motor Co., Ltd.
HMC has slightly lower modeled downside risk, despite its lower overall score.
NKE
NIKE, Inc.
NKE has the edge over HMC overall, supported by stronger valuation and stronger fundamentals.
HMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Strong |
HMC's revenue and balance sheet are currently healthy, and its cash flow is stable, but its profitability is under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
HMC PE Valuation
HMC has no meaningful PE right now: it lost money over the past year.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
HMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
HMC has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
HMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.81 | -131% |
| Q1 2026 | -$2.11 | -164% |
| Q4 2025 | $2.25 | -45% |
| Q3 2025 | $2.75 | -28% |
| Q2 2025 | $2.63 | -40% |
| Q1 2025 | $3.29 | -22% |
| Q4 2024 | $4.08 | +14% |
| Q3 2024 | $3.83 | +9.4% |
HMC has swung to a loss: it lost $0.81 per share over the past year, after a profit the year before.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over HMC on earnings quality, reporting a profit while its opponent remains loss making.
HMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $38B | +14% |
| Q1 2026 | $36.5B | +8.6% |
| Q4 2025 | $33.5B | -3.4% |
| Q3 2025 | $33.2B | -1.9% |
| Q2 2025 | $33.5B | -1.2% |
| Q1 2025 | $33.6B | -1.3% |
| Q4 2024 | $34.7B | +2.6% |
| Q3 2024 | $33.8B | +8.2% |
HMC has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8.8% | +4.2 points |
| Q1 2026 | -17% | -19 points |
| Q4 2025 | 2.9% | -4.3 points |
| Q3 2025 | 3.7% | -15 points |
| Q2 2025 | 4.6% | -4.4 points |
| Q1 2025 | 1.4% | -4.3 points |
| Q4 2024 | 7.2% | +0.1 points |
| Q3 2024 | 19% | +13 points |
HMC has the edge over NKE on profitability, with a higher operating margin.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
HMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.2B | -$1.4B |
| Q1 2026 | $870.1M | +$1.8B |
| Q4 2025 | $612.2M | +$1.3B |
| Q3 2025 | $726.9M | +$772.3M |
| Q2 2025 | -$719.2M | $0 |
| Q1 2025 | -$942.2M | $0 |
| Q4 2024 | -$683.5M | $0 |
| Q3 2024 | -$45.5M | $0 |
HMC has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
HMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.7% | +62.8M shares |
| 1 year | 0% | -42.7K shares |
| 3 years | -15% | -257M shares |
| 5 years | -19% | -326M shares |
| Available history | -20% | -359M shares |
HMC has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $576,658 |
| Q4 2025 | — |
| Q3 2025 | $1.9B |
| Q2 2025 | $2.3B |
| Q1 2025 | $2.7B |
| Q4 2024 | $423.3M |
| Q3 2024 | $1.3B |
HMC spent $1.9B buying back its own shares over the past year, down 71% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
HMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.9x | Net Cash |
| Q1 2026 | 8.6x | High |
| Q4 2025 | 4.9x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.8x | Moderate |
| Q3 2024 | 2.5x | Moderate |
HMC has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
HMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.4 | Neutral |
| Stochastic | 71.9 | Neutral |
HMC's weekly RSI is 58 (neutral) and its Stochastic is 72 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
HMC PE vs Consumer Cyclical Sector
| Metric | HMC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HMC has no meaningful PE right now: it lost money over the past year.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
HMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.6 | 0.2% below |
| 20 week MA | $31.9 | 5.3% above |
| 50 week MA | $29.4 | 14% above |
| 100 week MA | $29.7 | 13% above |
| 200 week MA | $30.3 | 11% above |
HMC has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
HMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.6 | $28.6 | -0.1% |
| 2021 | $28.6 | $28.1 | -1.7% |
| 2022 | $28.1 | $23.1 | -18% |
| 2023 | $23.1 | $30.9 | +34% |
| 2024 | $30.9 | $28.8 | -7% |
| 2025 | $28.8 | $29.8 | +3.6% |
| 2026 YTD | $29.8 | $33.5 | +13% |
HMC has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.